Berkshire Hathaway to Acquire OxyChem in $9.7 Billion Deal
Warren Buffett’s Berkshire Hathaway has announced plans to acquire OxyChem for $9.7 billion, marking its largest deal in three years. The acquisition underscores the conglomerate’s confidence in the chemicals sector and reinforces Buffett’s reputation for bold, long-term investments.